Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
Radiat Oncol. 2017 Dec 22;12(1):202. doi: 10.1186/s13014-017-0938-1.
Radiat Oncol. 2017.
PMID: 29273076
Free PMC article.
Toxicities were graded according to the common terminology criteria for adverse events (CTCAE v 4.0). RESULTS: One (6%) patient developed acute grade 3 diarrhea. We did not record any other acute or late gastrointestinal or urogenital toxicity h …
Toxicities were graded according to the common terminology criteria for adverse events (CTCAE v 4.0). RESULTS: One (6%) …
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.
Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A, Costantin G, Ambrosino G.
Polistina FA, et al.
Radiother Oncol. 2011 May;99(2):120-3. doi: 10.1016/j.radonc.2011.05.016. Epub 2011 May 27.
Radiother Oncol. 2011.
PMID: 21621289
Local control was assessed according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria. RESULTS: Two grade 1 and Two grade 2 acute toxicities were observed, moreover one grade 2 late toxicity was recorded. The overall local response ratio was …
Local control was assessed according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria. RESULTS: Two grade 1 and Two …
Item in Clipboard
Cite
Cite